ClinicalTrials.Veeva

Menu

Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Pancreatic Cancer

Treatments

Diagnostic Test: Laboratory Blood test
Procedure: EUS with fine-needle aspiration of pancreatic cyst

Study type

Interventional

Funder types

Other

Identifiers

NCT03178812
HYMC-0018-17

Details and patient eligibility

About

This study aims to find a correlation between cytokines levels and malignancy potential of different cystic types.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with pancreatic cyst

Exclusion criteria

  • None

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Patients with pancreatic cysts
Active Comparator group
Description:
Fine-needle aspiration (FNA) by Endoscopic Ultrasound (EUS) will collect liquid from patients' pancreatic cysts to measure their Interleukin and TNF levels
Treatment:
Procedure: EUS with fine-needle aspiration of pancreatic cyst
Healthy volunteers
Active Comparator group
Description:
Laboratory blood test to measure Interleukin and TNF levels
Treatment:
Procedure: EUS with fine-needle aspiration of pancreatic cyst
Diagnostic Test: Laboratory Blood test

Trial contacts and locations

1

Loading...

Central trial contact

Yael Kopelman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems